← Back to Search

LC for Substance Use Disorder

N/A
Waitlist Available
Led By Liliane Windsor, PhD
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months
Awards & highlights

Study Summary

This trial will test different combinations of a manualized intervention aimed at reducing health inequalities related to alcohol and illicit drug use, in order to find the most efficient and sustainable option.

Eligible Conditions
  • Substance Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Days of Alcohol or Substance Misuse in the Past 30 Days
Secondary outcome measures
Number of People Abstinent From Alcohol and Drug Use

Trial Design

16Treatment groups
Experimental Treatment
Group I: QLW-PFExperimental Treatment2 Interventions
Group intervention where participants learn to develop and implement personal goals that are measurable, attainable, realistic, and time bound. Intervention includes 9 sessions. Quality of Life wheel, Peer Facilitator (PF)
Group II: QLW- LCExperimental Treatment2 Interventions
Group intervention where participants learn to develop and implement personal goals that are measurable, attainable, realistic, and time bound. Intervention includes 9 sessions. Quality of Life Wheel, Licensed Clinician (LC)
Group III: QLW & Capacity Building ProjectCBP- LCExperimental Treatment3 Interventions
Combination of goal development and implementation with community mobilization intervention including 9 weekly sessions spread across 15 weeks. Licensed Clinician (LC)
Group IV: QLW & CD & CBP-LCExperimental Treatment4 Interventions
Combination of group behavioral intervention, goal development and implementation, and community mobilization intervention including 15 weekly sessions.Licensed Clinician (LC)
Group V: QLW & CBP- PFExperimental Treatment3 Interventions
Combination of goal development and implementation with community mobilization intervention including 9 weekly sessions spread across 15 weeks.Peer Facilitator (PF)
Group VI: PFExperimental Treatment1 Intervention
This condition will include 3 core sessions that are not a part of the components being tested. These are support sessions to the components being tested and is hypothesized to have the smallest impact on substance use outcomes. Peer Facilitator (PF)
Group VII: LCExperimental Treatment1 Intervention
This condition will include 3 core sessions that are not a part of the components being tested. These are support sessions to the components being tested and is hypothesized to have the smallest impact on substance use outcomes.Licensed Clinician (LC)
Group VIII: CD-LCExperimental Treatment2 Interventions
Group behavioral intervention with 9 weekly sessions lasting 2 hours. Critical Dialogue (CD), Licensed Clinician (LC).
Group IX: CD- PFExperimental Treatment2 Interventions
Group behavioral intervention with 9 weekly sessions lasting 2 hours. Critical Dialogue (CD), Peer Facilitator (PF)
Group X: CD & QLW- PFExperimental Treatment3 Interventions
Combination of group behavioral intervention and community mobilization intervention including 15 weekly sessions.Peer Facilitator (PF)
Group XI: CD & QLW- LCExperimental Treatment3 Interventions
Combination of group behavioral intervention and community mobilization intervention including 15 weekly sessions.Licensed Clinician (LC)
Group XII: CD & QLW & CBP- PFExperimental Treatment4 Interventions
Combination of group behavioral intervention, goal development and implementation, and community mobilization intervention including 15 weekly sessions.Peer Facilitator (PF)
Group XIII: CD & CBP- PFExperimental Treatment3 Interventions
Combination of group behavioral intervention and community mobilization intervention including 15 weekly sessions. Peer Facilitator (PF)
Group XIV: CD & CBP- LCExperimental Treatment3 Interventions
Combination of group behavioral intervention and community mobilization intervention including 15 weekly sessions.Licensed Clinician (LC)
Group XV: CBP- PFExperimental Treatment2 Interventions
Group community mobilizing intervention with 9 weekly sessions spread in 15 weeks. Capacity Building Project (CBP), Peer Facilitator (PF)
Group XVI: CBP- LCExperimental Treatment2 Interventions
Group community mobilizing intervention with 9 weekly sessions spread in 15 weeks. Capacity Building Project (CBP), Licensed Clinician (LC)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LC
2010
N/A
~710
Quality of Life Wheel
2017
N/A
~610
Capacity Building Project
2017
N/A
~610
PF
2017
Completed Phase 2
~690
Critical Dialogue
2021
N/A
~1830

Find a Location

Who is running the clinical trial?

North Jersey Community Research InitiativeUNKNOWN
3 Previous Clinical Trials
1,287 Total Patients Enrolled
University of MichiganOTHER
1,797 Previous Clinical Trials
6,377,456 Total Patients Enrolled
National Development and Research Institutes, Inc.OTHER
37 Previous Clinical Trials
12,344 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
TrialsJournal
Optimizing a Community-engaged Multi-level Group Intervention to Reduce Substance Use: An Application of the Multiphase Optimization Strategy
Windsor, Liliane Cambraia, Newark Community Collaborative Board (NCCB), Ellen Benoit, Douglas Smith, Rogério M. Pinto, and Kari C. Kugler. 2018. “Optimizing a Community-engaged Multi-level Group Intervention to Reduce Substance Use: An Application of the Multiphase Optimization Strategy”. Trials. Springer Science and Business Media LLC. doi:10.1186/s13063-018-2624-5.
Translational Behavioral MedicineJournal
Enhancing Behavioral Intervention Science: Using Community-based Participatory Research Principles with the Multiphase Optimization Strategy
Windsor, Liliane Cambraia, Ellen Benoit, Rogério M Pinto, Marya Gwadz, and Warren Thompson. 2021. “Enhancing Behavioral Intervention Science: Using Community-based Participatory Research Principles with the Multiphase Optimization Strategy”. Translational Behavioral Medicine. Oxford University Press (OUP). doi:10.1093/tbm/ibab032.
clinicaltrials.govStudy
Community Wise: An Innovative Multi-level Intervention to Reduce Alcohol and Illegal Drug Use
Liliane Cambraia Windsor 2017. "Community Wise: An Innovative Multi-level Intervention to Reduce Alcohol and Illegal Drug Use". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02951455.
~73 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top